Do patients initiate therapy? Primary non-adherence to statins and antidepressants in Iceland
Summary Background Primary non‐adherence occurs when a drug has been prescribed but the patient fails to have it dispensed at the pharmacy. Aims To assess primary non‐adherence to statins and antidepressants in Iceland, the association of demographic factors with primary non‐adherence, and the time...
Saved in:
Published in | International journal of clinical practice (Esher) Vol. 69; no. 5; pp. 597 - 603 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.05.2015
Hindawi Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
Background
Primary non‐adherence occurs when a drug has been prescribed but the patient fails to have it dispensed at the pharmacy.
Aims
To assess primary non‐adherence to statins and antidepressants in Iceland, the association of demographic factors with primary non‐adherence, and the time from when a prescription is issued until it is dispensed.
Methods
Data on patients receiving a new prescription for a statin or an antidepressant from the Primary Health Care database were linked with dispensing histories from The Icelandic Prescription Database. The proportion of patients who did not have their prescription dispensed within a year from issuing (primary non‐adherent) was assessed, as well as the time from issue until dispensing. Associations between demographic factors and primary non‐adherence were estimated using logistic regression.
Results
The overall primary non‐adherence was 6.3% and 8.0% for statins and antidepressants, respectively. The majority of patients had their prescription dispensed within 7 days (85% for statins, 87% for antidepressants). Being disabled and receiving a prescription for an expensive drug was associated with higher rates of primary non‐adherence.
Conclusion
The rate of primary non‐adherence to statins and antidepressants in Iceland is low. Vulnerable groups such as the disabled should be given special attention when new drugs are prescribed. |
---|---|
Bibliography: | Icelandic Research Fund ark:/67375/WNG-48FVZ1LW-0 istex:D91AAB2463A9B3F12FF6828ADABBD80665884180 ArticleID:IJCP12558 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1368-5031 1742-1241 |
DOI: | 10.1111/ijcp.12558 |